Improved analysis of 1H‐MR spectra in the presence of mobile lipids

Focal brain lesions can be associated with proton magnetic resonance spectra (1H‐MRS)‐detectable mobile lipids, reflecting severe tissue degradation and necrosis. However, advanced fitting procedures, such as the LCModel, fail to adequately fit spectra in the presence of lipid resonances. To overcome this, different approaches to generate lipid model spectra were compared using a phantom, real in vivo data, and simulated data. Twenty‐six in vivo short‐echo time (TE) 1H‐MRS from 21 malignant gliomas, four infections, and one ischemia were analyzed to evaluate the performance of the modified LCModel fit. Adding simulated aliphatic resonances at 1.3 and 0.9 ppm improved the overall fitting quality remarkably and allowed good separation of lactate and alanine. Also, a better differentiation of glioblastomas and anaplastic gliomas was achieved. In conclusion, we propose a simple way to efficiently include lipid resonances in the LCModel, allowing a better fit of in vivo short‐TE 1H‐MRS, and demonstrate the diagnostic potential of quantitative assessment of mobile lipids in brain tumors. Magn Reson Med 46:615–618, 2001. © 2001 Wiley‐Liss, Inc.

[1]  J S Duncan,et al.  Short echo time single‐voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging–negative temporal lobe epilepsy: Different biochemical profile compared with hippocampal sclerosis , 1999, Annals of neurology.

[2]  Ian C. P. Smith,et al.  1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.

[3]  Risto A. Kauppinen,et al.  1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosis , 1999, Nature Medicine.

[4]  K. Behar,et al.  Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.

[5]  M Ala-Korpela,et al.  1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. , 1994, Journal of lipid research.

[6]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[7]  W M Bovée,et al.  Improved quantification of in vivo1H NMR spectra by optimization of signal acquisition and processing and by incorporation of prior knowledge into the spectral fitting , 1990, Magnetic resonance in medicine.

[8]  R. Sauter,et al.  Intratumoral lipids in 1H MRS in vivo in brain tumors: experience of the Siemens cooperative clinical trial. , 1996, Anticancer research.

[9]  P. Williamson,et al.  The use of a priori knowledge to quantify short echo in vivo 1h mr spectra , 1995, Magnetic resonance in medicine.

[10]  Bernadette Lipinski,et al.  Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study , 2000, Biological Psychiatry.

[11]  J A Sorenson,et al.  Localized 2D J‐resolved H MR spectroscopy of human brain tumors in vivo , 1996, Journal of magnetic resonance imaging : JMRI.

[12]  J Hennig,et al.  Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.

[13]  A Moreno,et al.  Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. , 1997, Cancer research.

[14]  E. Gotsis,et al.  In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors. , 1996, Anticancer research.

[15]  P. Matarrese,et al.  1H‐MRS lipid signal modulation and morphological and ultrastructural changes related to tumor cell proliferation , 1999, Magnetic resonance in medicine.

[16]  D. Saunders,et al.  Discrimination of Metabolite from Lipid and Macromolecule Resonances in Cerebral Infarction in Humans Using Short Echo Proton Spectroscopy , 1997, Journal of magnetic resonance imaging : JMRI.

[17]  T Ernst,et al.  MR spectroscopy and diffusion-weighted MR imaging in focal brain lesions in AIDS. , 1997, Neuroimaging clinics of North America.

[18]  D. Arnold,et al.  Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. , 2000, Neurosurgery.

[19]  D P Auer,et al.  On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain , 1995, NMR in biomedicine.